| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
37,068 |
30,436 |
$3.00M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14,010 |
12,447 |
$801K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,930 |
3,918 |
$360K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
10,871 |
10,670 |
$345K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,944 |
3,936 |
$329K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,236 |
2,225 |
$187K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,411 |
1,354 |
$109K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
805 |
805 |
$76K |
| 99215 |
Prolong outpt/office vis |
671 |
531 |
$68K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,011 |
2,836 |
$43K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,050 |
1,044 |
$27K |
| 0001A |
|
319 |
317 |
$18K |
| 86580 |
|
2,305 |
2,297 |
$17K |
| 0002A |
|
277 |
276 |
$17K |
| 0072A |
|
188 |
180 |
$15K |
| 0071A |
|
167 |
161 |
$13K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
489 |
482 |
$9K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
584 |
469 |
$8K |
| 0003A |
|
95 |
78 |
$6K |
| 99000 |
|
2,207 |
1,972 |
$5K |
| 0124A |
|
52 |
52 |
$4K |
| 90674 |
|
1,043 |
1,035 |
$3K |
| 99383 |
|
25 |
25 |
$2K |
| 99381 |
|
25 |
25 |
$2K |
| 0073A |
|
29 |
26 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
124 |
123 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
37 |
37 |
$2K |
| 99188 |
|
98 |
98 |
$1K |
| 94010 |
|
44 |
44 |
$1K |
| 69210 |
|
33 |
28 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
121 |
118 |
$902.05 |
| 90671 |
|
29 |
29 |
$777.74 |
| 99173 |
|
233 |
228 |
$588.52 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
502 |
380 |
$585.30 |
| A7015 |
Aerosol mask, used with dme nebulizer |
541 |
413 |
$437.32 |
| 94761 |
|
447 |
324 |
$400.29 |
| 96127 |
|
69 |
69 |
$332.93 |
| 90651 |
|
794 |
751 |
$169.73 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
585 |
469 |
$114.68 |
| 90734 |
|
722 |
667 |
$92.58 |
| 90686 |
|
2,279 |
2,007 |
$63.26 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
443 |
347 |
$53.49 |
| 90670 |
|
742 |
685 |
$50.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
189 |
188 |
$18.42 |
| 90700 |
|
316 |
285 |
$11.32 |
| 91300 |
|
248 |
219 |
$0.59 |
| 91307 |
|
30 |
26 |
$0.30 |
| 90648 |
|
101 |
96 |
$0.00 |
| 90621 |
|
1,079 |
1,013 |
$0.00 |
| G9920 |
Screening performed and negative |
143 |
141 |
$0.00 |
| 90713 |
|
42 |
38 |
$0.00 |
| 90715 |
|
119 |
108 |
$0.00 |
| 90707 |
|
259 |
247 |
$0.00 |
| 90633 |
|
267 |
253 |
$0.00 |
| 90685 |
|
41 |
41 |
$0.00 |
| 90688 |
|
428 |
413 |
$0.00 |
| 90698 |
|
256 |
233 |
$0.00 |
| 90716 |
|
293 |
280 |
$0.00 |
| 90723 |
|
24 |
24 |
$0.00 |
| 90680 |
|
324 |
291 |
$0.00 |
| 90744 |
|
108 |
95 |
$0.00 |